BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16168109)

  • 1. Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells.
    Siddiqui RA; Zerouga M; Wu M; Castillo A; Harvey K; Zaloga GP; Stillwell W
    Breast Cancer Res; 2005; 7(5):R645-54. PubMed ID: 16168109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propofol and bupivacaine in breast cancer cell function in vitro - role of the NET1 gene.
    Ecimovic P; Murray D; Doran P; Buggy DJ
    Anticancer Res; 2014 Mar; 34(3):1321-31. PubMed ID: 24596379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation.
    Mathew B; Lennon FE; Siegler J; Mirzapoiazova T; Mambetsariev N; Sammani S; Gerhold LM; LaRiviere PJ; Chen CT; Garcia JG; Salgia R; Moss J; Singleton PA
    Anesth Analg; 2011 Mar; 112(3):558-67. PubMed ID: 21156980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 2 anesthetic techniques on the postoperative proinflammatory and anti-inflammatory cytokine response and cellular immune function to minor surgery.
    Schneemilch CE; Ittenson A; Ansorge S; Hachenberg T; Bank U
    J Clin Anesth; 2005 Nov; 17(7):517-27. PubMed ID: 16297751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anesthetic propofol epigenetically regulates breast cancer trastuzumab resistance through IL-6/miR-149-5p axis.
    Tian D; Tian M; Ma ZM; Zhang LL; Cui YF; Li JL
    Sci Rep; 2020 Jun; 10(1):8858. PubMed ID: 32483313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propofol inhibits lung cancer cell viability and induces cell apoptosis by upregulating microRNA-486 expression.
    Yang N; Liang Y; Yang P; Yang T; Jiang L
    Braz J Med Biol Res; 2017 Jan; 50(1):e5794. PubMed ID: 28076456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lidocaine effects on neutrophil extracellular trapping and angiogenesis biomarkers in postoperative breast cancer patients with different anesthesia methods: a prospective, randomized trial.
    Zhang W; Liu J; Li X; Bai Z; Sun Y; Chen X
    BMC Anesthesiol; 2024 Apr; 24(1):162. PubMed ID: 38678209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising Effects of
    Augimeri G; Bonofiglio D
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Propofol and Etomidate on the Proliferation, Cell-cycle Distribution, Apoptosis and Necrosis of Pancreatic Tumour Cells.
    Malsy M; Graf B; Hofer V; Bitzinger D; Bundscherer A
    In Vivo; 2022; 36(6):2722-2729. PubMed ID: 36309382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin and histone deacetylase inhibitor based anti-inflammatory nanoplatform for epithelial-mesenchymal transition suppression and metastatic tumor treatment.
    Jiang T; Xie L; Zhou S; Liu Y; Huang Y; Mei N; Ma F; Gong J; Gao X; Chen J
    J Nanobiotechnology; 2022 Aug; 20(1):394. PubMed ID: 36045429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of equipotent doses of propofol and sevoflurane on endoplasmic reticulum stress during breast cancer surgery.
    Oh CS; Hong SW; Park S; Kwon Y; Kim SH
    Korean J Anesthesiol; 2022 Dec; 75(6):487-495. PubMed ID: 35760393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the Hypnotic Alkylphenol Derivative Propofol on Breast Cancer Progression. A Focus on Preclinical and Clinical Studies.
    Bimonte S; Cascella M; Forte CA; Esposito G; Del Prato F; Raiano N; Del Prete P; Cuomo A
    In Vivo; 2021; 35(5):2513-2519. PubMed ID: 34410937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifications of Plasma Membrane Organization in Cancer Cells for Targeted Therapy.
    Choromańska A; Chwiłkowska A; Kulbacka J; Baczyńska D; Rembiałkowska N; Szewczyk A; Michel O; Gajewska-Naryniecka A; Przystupski D; Saczko J
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33806009
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Giordano C; Plastina P; Barone I; Catalano S; Bonofiglio D
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32224850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing cancer immunotherapy during the unexploited immediate perioperative period.
    Matzner P; Sandbank E; Neeman E; Zmora O; Gottumukkala V; Ben-Eliyahu S
    Nat Rev Clin Oncol; 2020 May; 17(5):313-326. PubMed ID: 32066936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical stress and cancer progression: the twisted tango.
    Chen Z; Zhang P; Xu Y; Yan J; Liu Z; Lau WB; Lau B; Li Y; Zhao X; Wei Y; Zhou S
    Mol Cancer; 2019 Sep; 18(1):132. PubMed ID: 31477121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a colorimetric assay to evaluate the proliferation of canine mammary tumor cells exposed to propofol.
    Argano M; De Maria R; Rodlsberger K; Buracco P; Menzies MPL
    Can J Vet Res; 2019 Apr; 83(2):149-153. PubMed ID: 31097877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer.
    Chu X; Zhou Q; Xu Y; Jiang J; Li Q; Zhou Q; Wu Q; Jin M; Wang H; Gu Y; Wang X; Wang B; He S; He X; Wu C; Zhang F; Zhang Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):100. PubMed ID: 30795784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of propofol on human cholangiocarcinoma and the associated mechanisms.
    Zhang Z; Zang M; Wang S; Wang C
    Exp Ther Med; 2019 Jan; 17(1):472-478. PubMed ID: 30651824
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.